Interventional Cardiology Developments in Cardiac Stenting: Comparative Studies Raise Questions Adding fuel to recent concerns about the cost effectiveness, safety, and off-label use of drug-eluting s
They may not be medical technology experts, but industrial companies know what they like—the fat margins and attractive fundamentals of the medtech sector. By Pete Lawyer and Rob Alford This article i
Start-ups find lucrative opportunities in adjunctive technologies, or in non-radiology niches for the MRI market. In 2003, the Nobel Prize awarded to Paul Lauterbur and Peter Mansfield for their contr